Chapter 2 Progesterone Receptor Action in Leiomyoma and Endometrial Cancer

J. Julie Kim*, Elizabeth C. Sefton, Serdar E. Bulun

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Progesterone is a key hormone in the regulation of uterine function. In the normal physiological context, progesterone is primarily involved in remodeling of the endometrium and maintaining a quiescent myometrium. When pathologies of the uterus develop, specifically, endometrial cancer and uterine leiomyoma, response to progesterone is usually altered. Progesterone acts through mainly two isoforms of the progesterone receptor (PR), PRA and PRB which have been reported to exhibit different transcriptional activities. Studies examining the expression and function of the PRs in the normal endometrium and myometrium as well as in endometrial cancer and uterine leiomyoma are summarized here. The clinical use of progestins and the transcriptional activity of the PR on genes specific to endometrial cancer and leiomyoma are described. An increased understanding of the differential expression of PRs and response to progesterone in these two diseases is critical in order to develop more efficient and targeted therapies.

Original languageEnglish (US)
Pages (from-to)53-85
Number of pages33
JournalProgress in Molecular Biology and Translational Science
Issue numberC
StatePublished - 2009

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology


Dive into the research topics of 'Chapter 2 Progesterone Receptor Action in Leiomyoma and Endometrial Cancer'. Together they form a unique fingerprint.

Cite this